Announcement on Implementing Change of the Stock Abbreviation
Filed with SSE · · 2 pages · Chinese
GuiZhou SanLi Pharmaceutical Co., Ltd. on 6ix
Earlier from GuiZhou SanLi Pharmaceutical
- Announcement on the Wholly-owned Subsidiary’s Exit from a Joint Investment Enterprise with a Related Party and Termination of the Related Party Transaction
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Indicative Announcement on Execution of an Acting-in-Concert Agreement by the Controlling Shareholder and Resulting Change in Interests
- Announcement on Resolutions of the 15th Meeting of the 4th Board of Supervisors
- Announcement on Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks
Later from GuiZhou SanLi Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Signing of Technology Transfer Agreement with Hainan University
- Announcement on Resolutions of the 20th Meeting of the 4th Board of Directors
- Announcement on Resolutions of the 21st Meeting of the 4th Board of Directors
- Announcement on Expected Decrease in Performance for 2025
Follow GuiZhou SanLi Pharmaceutical into a list and get an email when it puts out news.
Follow GuiZhou SanLi Pharmaceutical